Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer.
Ferrari SM, Elia G, Ragusa F, Paparo SR, Mazzi V, Miccoli M, Galdiero MR, Varricchi G, Foddis R, Guglielmi G, Spinelli C, La Motta C, Benvenga S, Antonelli A, Fallahi P.
Ferrari SM, et al. Among authors: guglielmi g.
Expert Opin Investig Drugs. 2021 Sep;30(9):913-921. doi: 10.1080/13543784.2021.1972971. Epub 2021 Sep 6.
Expert Opin Investig Drugs. 2021.
PMID: 34428101
Review.